SciHub
文献互助
期刊查询
一搜即达
科研导航
交流社区
登录
注册
发布
文献
求助
首页
我的求助
捐赠本站
西西
Lv3
370 积分
2022-02-16 加入
最近求助
最近应助
互助留言
Targeting KRAS in cancer
21天前
已完结
New route to target RAS
21天前
已完结
COLUMBUS 7-year update: A randomized, open-label, phase III trial of encorafenib plus binimetinib versus vemurafenib or encorafenib in patients with BRAF V600E/K-mutant melanoma
25天前
已完结
A next-generation BRAF inhibitor overcomes resistance to BRAF inhibition in patients with BRAF-mutant cancers using pharmacokinetics-informed dose escalation
25天前
已完结
A proof-of-concept study of sequential treatment with the HDAC inhibitor vorinostat following BRAF and MEK inhibitors in BRAFV600mutated melanoma
25天前
已完结
A Practical Review of Encorafenib and Binimetinib Therapy Management in Patients with BRAF V600E-Mutant Metastatic Non-Small Cell Lung Cancer
1个月前
已完结
First-in-human study of naporafenib (LXH254) with or without spartalizumab in adult patients with advanced solid tumors harboring MAPK signaling pathway alterations
1个月前
已完结
Thyroid Cancer: A Review
3个月前
已完结
Efficacy and safety of 'Second Adjuvant' therapy with BRAF/MEK inhibitors after local therapy for recurrent melanoma following adjuvant PD-1 based immunotherapy
3个月前
已完结
Thyroid Cancer: A Review
3个月前
已完结
没有进行任何应助
非常感谢!
2年前
不是这篇文章
2年前
感谢,点赞,速度真快,帮大忙了
2年前
最近帖子
最近评论
没有发布任何帖子
没有发布任何评论